NouBio Inc Information

Bio-intelligent cell-based manufacturing of synthetic animal serum replacements & deep technology for foods, vaccines & therapies to unlock the reality of the $4trillion dollar bioeconomy. Pre-seed investment from Big Idea Ventures in 2022. First market-ready product: NouSerum (powder & liquid) has 300 serum proteins, GRAS, & can reduce cell-based biomanufacturing production costs whilst maintaining high performance similar to Fetal Bovine Serum (FBS). We pioneering a bio-intelligent manufacturing future to unlock all innovations in cell-based vaccines, cell therapy, biosimilars, human tissue, regenerative medicine, cell-based foods [meat, fish, fats, milk], & industrial synbio. Our first product: NouSerum: A full FBS replacement that reduces production costs whilst maintaining high performance. NouSerum has ~300 serum proteins to act as a full FBS replacement, is GRAS certified, and is free from GMOs to eliminate regulatory issues. It is powder-based and can be stored at room temperature. Data shows that NouSerum increases cell density and has antimicrobial properties. NouSerum is fully scalable and has been tested on multiple cell lines. Email info@noubio.co to purchase our products. Launching 2024: GMP liquid products, Xeno-free products, concentrated growth factors, & robotic cellular farming deep technologies.